Comparison between Curis Lifesciences IPO and Tankup Engineers IPO.
Curis Lifesciences IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Tankup Engineers IPO is a SME Bookbuilding proposed to list at NSE SME.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Hem Finlease Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Curis Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the Tankup Engineers IPO is up to ₹18.55 Cr. The final issue price of Curis Lifesciences IPO is and of Tankup Engineers IPO is ₹140.00 per share.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹133.00 per share | |
| Issue Price (Upper) | ₹140.00 per share | |
| Issue Price (Final) | ₹140.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 22,50,000 shares | 13,25,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹18.55 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 22,50,000 shares | 13,25,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹18.55 Cr |
Curis Lifesciences IPO opens on , while Tankup Engineers IPO opens on Apr 23, 2025. The closing date of Curis Lifesciences IPO and Tankup Engineers IPO is , and Apr 25, 2025, respectively.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Anchor Bid Date | Apr 22, 2025 | |
| Issue Open | Apr 23, 2025 | |
| Issue Close | Apr 25, 2025 | |
| Basis Of Allotment (Tentative) | Apr 28, 2025 | |
| Initiation of Refunds (Tentative) | Apr 29, 2025 | |
| Credit of Share (Tentative) | Apr 29, 2025 | |
| Listing date (Tentative) | Apr 30, 2025 | |
| Anchor Lockin End date 1 | May 28, 2025 | |
| Anchor Lockin End date 2 | Jul 27, 2025 |
Curis Lifesciences IPO P/E ratio is , as compared to Tankup Engineers IPO P/E ratio of 21.26.
| Curis Lifesciences IPO | Tankup Engineers IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Curis Lifesciences Limited Financial Information (Restated)
| Tankup Engineers Limited Financial Information (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.68 | 100.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹74.13 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 145.20% | 107.11% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 34.89% | 46.49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.86 | 1.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 84.12% | 69.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 0 shares while in Tankup Engineers IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Curis Lifesciences IPO and 2,58,000 shares in Tankup Engineers IPO.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | 3,85,000 shares |
| Market Maker Reserveration | 0 shares | 70,000 shares |
| QIB | 0 shares | 2,58,000 shares |
| NII | 0 shares | 1,94,000 shares |
| RII | 0 shares | 4,52,000 shares |
| Employee | 0 shares | 36,000 shares |
| Others | ||
| Total | 0 shares | 13,25,000 shares |
Curis Lifesciences IPO subscribed in total, whereas Tankup Engineers IPO subscribed 124.67x.
| Curis Lifesciences IPO | Tankup Engineers IPO | |
|---|---|---|
| QIB (times) | 43.65x | |
| NII (times) | 437.62x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 46.51x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 124.67x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
